McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us
Market Intel: Liquid Biopsies For Cancer Screening – Far From Reach Or Close At Hand?

Market Intel: Liquid Biopsies For Cancer Screening – Far From Reach Or Close At Hand?

by McKesson Ventures | May 11, 2018 | Media Coverage

Senior vice president and managing director of McKesson Ventures Tom Rodgers reported that the firm broke precedent with its investment in GRAIL Inc. The investment was unusual for the company in two ways; it was one of the firm’s larger spends, and it was also toward...

Recent Posts

  • Latent Raises $80M to Close the Gap Between Diagnosis and Treatment
  • Midi Health Surpasses $1B Valuation, Igniting a New Era for Women’s Health
  • Oath Surgical Announces AI-Native Surgical Centers Powered by NVIDIA
  • Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies
  • Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings